Braeburn Is A Commercial Stage Pharmaceutical Company Based In Princetonnew Jerseydedicated To Improving The Management Of Opioid Use Disorderoud The Company Focuses On Developing Long Acting Medications And Emphasizes Patient Centered Care And Community Supportbraeburn Actively Works To Reduce The Stigma Associated With Addiction Through Initiatives Like Patient Forums And Participation In Advocacy Events The Flagship Productbrixadia Cbuprenorphine Is Designed For Oud And Is Available In Extended Release Formulationsbraeburn Promotes Individualized Treatment Plans And Integrates Medication With Counseling And Support Servicesthe Company Engages Directly With Patients To Gather Insights And Collaborates With Healthcare Providers To Create Comprehensive Treatment Strategies Braeburn Serves Individuals With Oudhealthcare Providersand Advocacy Organizationsthe Company Has Raised Significant Funding And Is Positioned To Play A Vital Role In The Expanding Oud Treatment Markettheir Innovative Approach Includes Advancements In Medical Delivery Systemscontributing To Their Mission Of Enhancing Recovery Solutions
